1. Text: | Print|

      Police closes investigation on GSK China's bribery case

      2014-05-14 11:24 Xinhua Web Editor: Qin Dexing
      1

      Police finished their investigation on the suspected bribery case of GlaxoSmithKline (GSK) China and handed it over to prosecutors, local police said in Changsha on Wednesday.

      Prosecutors have started their examination of the case, said the police of Changsha, capital of central China's Hunan Province, in a statement.

      The case involves a total of 46 suspects, with William Mark Reilly, a British national and manager of GSK China, among them. After ten months of investigation, police found that Reilly had ordered his subordinates to commit bribery.

      Reilly allegedly pressed his sales teams to bribe hospitals, doctors, other medical institutions and organizations through various means and gained illegal revenue worth billions.

      Reilly assumed the office of general manager of the prescription drug division of GSK China in January 2009.

      He and two other executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry and commerce departments of Beijing and Shanghai to escape investigation.

      Investigations confirmed that GSK China intentionally raised the price of its drugs in the Chinese market by declaring higher prices to Chinese customs.

      According to the police, in the most extreme case, the price for the Chinese market was seven times that for others.

      The company's high profits and bribery expenses contributed to price floating, police said.

      GSK China's revenue in China increased from about 3.9 billion yuan in 2009 to 6.9 billion yuan in 2012.

      According to police, Reilly and his colleagues disguised the illegal revenue in the Chinese market by forging financial accounts. They faked transactions between GSK China and several foreign companies of GSK, making the revenue look like funds they received to purchase raw material in China, they added.

      The company sponsored its sales representatives in committing bribery and also deployed a highly stressful promotion policy for its sales team, forcing its employees to bribe to achieve soaring sales targets, according to the police.

      Reilly and other senior managers tried every effort to cover the illegal sale practice during regular checks by regulatory authorities, the police said.

      In terms of sales of prescription drugs and vaccines, police found that all pharmaceutical factories and departments of GSK China nationwide had been involved in commercial bribery.

      Last July, police detained four senior executives of GSK China on suspicion of commercial bribery. They were identified as vice president and operation manager Liang Hong, vice president and human resources director Zhang Guowei, legal affairs director Zhao Hongyan, and business development manager Huang Hong. Reilly was not among them.

      Comments (0)
      Most popular in 24h
        Archived Content
      Media partners:

      Copyright ©1999-2018 Chinanews.com. All rights reserved.
      Reproduction in whole or in part without permission is prohibited.

      主站蜘蛛池模板: 污污视频网站免费观看| 亚洲日韩一区二区三区| 中文字幕视频免费在线观看| 波多野结衣中文一区二区免费| 亚洲国产欧美日韩精品一区二区三区| 波多野结衣在线免费观看| 亚洲成人免费网址| 麻豆视频免费播放| 亚洲中文无码av永久| 永久黄网站色视频免费观看 | 国产精品久久久亚洲| 中国一级全黄的免费观看| 亚洲国产成人精品无码区在线观看| 人妻免费一区二区三区最新| 亚洲AV色香蕉一区二区| 1000部拍拍拍18勿入免费视频软件 | 2022国内精品免费福利视频| 国产成人99久久亚洲综合精品| 你懂的在线免费观看| 91精品国产亚洲爽啪在线观看| 在线精品一卡乱码免费| 国产精品亚洲精品久久精品| 久久精品国产精品亚洲艾草网美妙| 中文字幕在线免费观看视频| 亚洲av色影在线| 夜夜爽免费888视频| 日韩电影免费在线观看网址| 国产精品亚洲A∨天堂不卡| 日韩精品内射视频免费观看| 亚洲妇女熟BBW| 亚洲国产日韩成人综合天堂| 99爱免费观看视频在线| 亚洲精品成a人在线观看☆| 浮力影院亚洲国产第一页| 亚洲黄色免费观看| 羞羞网站在线免费观看| 亚洲国产一区二区a毛片| 久久不见久久见中文字幕免费| 高清免费久久午夜精品 | 免费看无码自慰一区二区| 国产精品成人免费观看|